Black Diamond (BDTX) Upgraded to Buy: What Does It Mean for the Stock?Zacks Investment Research • Monday
Wall Street Analysts Predict a 129.25% Upside in Black Diamond (BDTX): Here's What You Should KnowZacks Investment Research • 04/08/24
Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual MeetingGlobeNewsWire • 04/07/24
How Much Upside is Left in Black Diamond Therapeutics (BDTX)? Wall Street Analysts Think 95.93%Zacks Investment Research • 03/22/24
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateGlobeNewsWire • 03/12/24
Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024GlobeNewsWire • 03/05/24
Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care ConferenceGlobeNewsWire • 02/28/24
Black Diamond Therapeutics Announces Corporate Update and Expected 2024 MilestonesGlobeNewsWire • 01/04/24
Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBMGlobeNewsWire • 12/13/23
Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateGlobeNewsWire • 11/06/23
Black Diamond Therapeutics Presents Dose Escalation Data Demonstrating Durable Responses in Patients with NSCLC from Phase 1 Trial of BDTX-1535GlobeNewsWire • 10/14/23
Black Diamond Therapeutics to Present Preclinical and Clinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsGlobeNewsWire • 10/04/23
Black Diamond Therapeutics Announces First Patients Dosed in Phase 1 Clinical Trial Expansion Cohorts Evaluating BDTX-1535 in Patients with Intrinsic Driver and Acquired Resistance EGFR Mutation Positive Non-Small Cell Lung CancerGlobeNewsWire • 09/11/23
Black Diamond Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateGlobeNewsWire • 08/11/23
Black Diamond Therapeutics: MasterKey Approach Validated With Lung Cancer UpdateSeeking Alpha • 08/03/23
Black Diamond Therapeutics Announces Pricing of Public Offering of Common StockGlobeNewsWire • 06/30/23
Black Diamond Therapeutics Announces Proposed Public Offering of Common StockGlobeNewsWire • 06/28/23